Trial Profile
Brain-derived neurotrophic factor in generalized anxiety disorder: results from a double-blind, placebo-controlled study of duloxetine treatment.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Apr 2013
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 27 Jul 2011 New trial record